News
FDA Approves First Blood Test for Alzheimer’s Diagnosis, Marking a Historic Shift in Early Detection
Lumipulse G pTau217/β-Amyloid 1-42—for the diagnosis of Alzheimer’s disease. It demonstrated 91.7% sensitivity and 97.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback